Sign in
908 TOTAL NEOADJUVANT THERAPY VERSUS NEOADJUVANTCHEMORADIATION IN PATIENTS WITH STAGE II-III RECTAL CANCER: IMPACT ON PATHOLOGIC COMPLETE RESPONSE, TUMOR DOWNSTAGING, AND SURVIVAL RATES
Abstract   Peer reviewed

908 TOTAL NEOADJUVANT THERAPY VERSUS NEOADJUVANTCHEMORADIATION IN PATIENTS WITH STAGE II-III RECTAL CANCER: IMPACT ON PATHOLOGIC COMPLETE RESPONSE, TUMOR DOWNSTAGING, AND SURVIVAL RATES

Paolo Goffredo, Adil Khan, Sarah Bell, Xiang Gao, Kyle Freischlag, Pashtoon M. Kasi, Y. Nancy You and Imran Hassan
Gastroenterology (New York, N.Y. 1943), Vol.158(6), pp.S-1542-S-1542
05/2020
DOI: 10.1016/S0016-5085(20)34533-9

View Online

Details

Metrics

21 Record Views